Related Experiment Video
Updated: Jan 25, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Clostridium difficile Infection-Daily Symptoms (CDI-DaySyms™) questionnaire: psychometric characteristics and
George H Talbot1, Leah Kleinman2, Evan Davies3
1Talbot Advisors LLC, PO Box 2121, Anna Maria, FL, 34217, USA. ghtalbot@gmail.com.
The Clostridium difficile infection (CDI)-Daily Symptoms (CDI-DaySyms™) questionnaire is a validated tool for measuring patient-reported symptoms. It demonstrates good psychometric properties and can be used as a clinical endpoint.
Area of Science:
- Medical research
- Clinical outcomes assessment
- Patient-reported outcomes
Background:
- Clostridium difficile infection (CDI) significantly impacts patient well-being.
- Accurate measurement of CDI symptoms is crucial for evaluating treatment efficacy.
- Patient-reported outcome (PRO) measures are essential for capturing the patient experience.
Purpose of the Study:
- To validate the Clostridium difficile infection (CDI)-Daily Symptoms (CDI-DaySyms™) patient-reported outcome (PRO) questionnaire.
- To assess its psychometric characteristics, including reliability and validity.
- To determine clinically meaningful improvement and responder thresholds for CDI symptoms.
Main Methods:
- Validation study integrated into two Phase III clinical trials (NCT01987895, NCT01983683).
- Evaluation in three stages: PRO content validation, psychometric assessment (reliability, construct validity), and determination of clinically meaningful improvement and responder thresholds.
- Utilized distribution-based methods for threshold determination.
Main Results:
- The CDI-DaySyms™ questionnaire includes 10 items across three domains: Diarrhea Symptoms, Abdominal Symptoms, and Systemic/Other Symptoms.
- Domain scores showed acceptable internal consistency and test-retest reliability.
- Responder thresholds were established for each domain, indicating meaningful change in CDI symptoms.
Conclusions:
- The CDI-DaySyms™ is a valid and reliable PRO measure for CDI symptoms.
- Its established measurement properties support its use as a clinical trial endpoint.
- Further research using anchor-based methods is recommended to confirm responder thresholds.
More Related Videos
Related Concept Videos
Characteristics of Life
Classical Conditioning in Daily Life
John B. Watson and Rosalie Rayner famously demonstrated the development of fear through classical conditioning in their experiment with Little Albert. They paired the...
Diabetes: Symptoms, Diagnosis, and Complications
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Asthma-III: Symptoms and Complications
Classification of Asthma
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:

